A Phase I/II Study of Irinotecan, Oxaliplatin, Capecitabine (XELOXIRI) and Bevacizumab as a First-Line Therapy for Patients with Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: experimental group:XELOXIRI/bevacizumab Primary outcome(s): DLT;MTD;RP2D;ORR Study Design: Single arm
创建时间：
2020-04-15
